How the product works:
Triclabendazole is a benzimidazole derivative with selective activity against liver flukes. It disrupts parasite metabolism and damages their outer structures, leading to elimination of both immature and adult stages.
Who it is recommended for:
Clinical studies and evidence:
Triclabendazole is recommended by the World Health Organization as the treatment of choice for fascioliasis. Clinical studies confirm its high efficacy across all parasite life stages, including early invasive forms, making it a standard therapy worldwide.
Indicated for the treatment of fascioliasis and other trematode infections affecting the liver and biliary system. Acts directly on the causative parasites, helping to resolve infection and related inflammatory symptoms.
Taken orally with food to enhance absorption. Dosage and treatment duration depend on body weight and type of infection and should be determined by a healthcare professional.
Contraindications
Side effects
